Jeffrey Farrow
2021 - Global Blood Therapeutics
Compensation breakdown
Non-Equity Incentive Plan | $190,000 |
---|---|
Option Awards | $1,102,132 |
Salary | $476,667 |
Stock Awards | $983,097 |
Other | $6,000 |
Total | $2,757,896 |
Farrow received $1.1M in option awards, accounting for 40% of the total pay in 2021.
Farrow also received $190K in non-equity incentive plan, $476.7K in salary, $983.1K in stock awards and $6K in other compensation.
Rankings
In 2021, Jeffrey Farrow's compensation ranked 4,767th out of 12,415 executives tracked by ExecPay. In other words, Farrow earned more than 61.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,767 | 62nd |
Manufacturing | 1,986 | 64th |
Chemicals And Allied Products | 837 | 65th |
Drugs | 749 | 64th |
Pharmaceutical Preparations | 536 | 65th |
Pay ratio
Jeffrey Farrow's Pay | $2,757,896 |
---|---|
Median Employee's Pay | $345,973 |
Pay Ratio | 8to 1 |
In 2021, the annual total compensation of Jeffrey Farrow was $2,757,896.
The annual total compensation of the median employee at Global Blood Therapeutics was $345,973.
The ratio of Jeffrey Farrow's pay to the pay of median employee was therefore 8 to one.
Farrow's colleagues
We found four more compensation records of executives who worked with Jeffrey Farrow at Global Blood Therapeutics in 2021.